End-stage Renal Disease
📧 Sign up to get email alerts when something new happens for End-stage Renal Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-04-19FDA Approved: DIANEAL PD-2 WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)
The FDA approved a supplemental application for Dianeal PD-2 with Dextrose, a peritoneal dialysis solution, submitted by Vantive US Healthca…
-
FDA approval · 2013-04-19FDA Approved: DIANEAL LOW CALCIUM WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)
FDA approved a supplemental application for Dianeal Low Calcium with Dextrose (a peritoneal dialysis solution) submitted by Vantive US Healt…
-
FDA approval · 2013-04-19FDA Approved: DIANEAL LOW CALCIUM WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)
The FDA approved a supplemental application for Dianeal Low Calcium with Dextrose, a peritoneal dialysis solution, manufactured by Vantive U…
-
FDA approval · 2013-04-18FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care de Mexico, S.A. de C.V.)
FDA approved a supplemental application for DELFLEX, a dialysis solution containing dextrose and electrolytes, manufactured by Fresenius Med…
-
FDA approval · 2013-04-18FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care North America)
The FDA approved a supplemental application for DELFLEX, a dialysis solution, submitted by Fresenius Medical Care North America.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-04-18Clinical Trial Update: Serum NGAL Levels in Hemodialysis (HD) Patients; Relation to Iron Status, HD and Intravenous (IV) Iron Administration [NA]
This clinical trial update examines serum NGAL levels in hemodialysis patients and their relationship to iron status and intravenous iron ad…
-
CLINICAL_TRIALS withdrawal · 2013-03-29Clinical Trial Update: A Multi-Center, Open-Label Study [Phase 1]
This document reports a Phase 1, multi-center open-label study sponsored by Chelsea Therapeutics that has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-03-29Clinical Trial Update: Comparison of Conventional Dialysis and the Allient System [NA]
This clinical trial compares conventional dialysis with the Allient System for patients with end-stage renal disease or chronic kidney disea…
-
CLINICAL_TRIALS trial_result · 2013-03-27Clinical Trial Update: Continuous Cardiac Arrhythmia Monitoring in Hemodialysis Patients
A completed clinical trial evaluated continuous cardiac arrhythmia monitoring in patients receiving hemodialysis, with results posted in 201…
-
CLINICAL_TRIALS withdrawal · 2013-03-06Clinical Trial Update: Assessment of the Sympathetic Nervous System Blockade of the Upper Limb After a Brachial Plexus Block in Patients With End Stage Renal Failure
A clinical trial evaluating sympathetic blockade after brachial plexus block in patients with end-stage renal disease has been withdrawn.
-
CLINICAL_TRIALS research · 2013-03-01Clinical Trial Update: Exercise and Vascular Function in Haemodialysis Patients [Phase 2]
A Phase 2 clinical trial update examining the effect of exercise on vascular function in haemodialysis patients with end-stage renal disease…
-
CLINICAL_TRIALS trial_result · 2013-02-26Clinical Trial Update: Application of Impedance Threshold Device Technologies to Treat and Prevent Hypotension During Dialysis [Phase 2]
A Phase 2 trial assessed impedance threshold device technologies for treating and preventing intradialytic hypotension in patients with end-…
-
CLINICAL_TRIALS trial_result · 2013-02-26Clinical Trial Update: Ertapenem Pharmacokinetics in Patients in Continuous Ambulatory Peritoneal Dialysis [Phase 4]
A Phase 4 clinical trial evaluated the pharmacokinetics of ertapenem in patients undergoing continuous ambulatory peritoneal dialysis due to…
-
FDA approval · 2013-02-22FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care North America)
FDA approved a supplemental application for DELFLEX submitted by Fresenius Medical Care North America, updating its formulation to include d…
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Comparison of Cardiac Index and Cardiac Output Effect During Maintenance Hemodialysis Between Acetate-Free and Acetate-Based Online Hemodiafiltration [Phase 4]
A Phase 4 trial comparing acetate-free and acetate-based online hemodiafiltration during maintenance hemodialysis evaluated effects on cardi…
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: Pharmacokinetic Profile and Pharmacodynamic Characteristics of a Furosemide High Dosage Formulation in Patients With Chronic Renal Failure Undergoing Peritoneal Dialysis [Phase 1]
This Phase 1 study reports the pharmacokinetic and pharmacodynamic characteristics of a high-dose furosemide formulation in patients with ch…
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: Perioperative Fluid Management in Patients Receiving Cadaveric Renal Transplants
Completed clinical trial evaluating perioperative fluid management in cadaveric renal transplant patients.
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: Reduce Cardiovascular Calcifications to Reduce QT Interval in Dialysis [NA]
This clinical trial update reports a completed study testing whether reducing cardiovascular calcifications can reduce the QT interval in pa…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Safety Study of the Vascular Wrap Paclitaxel-Eluting Mesh for Hemodialysis Vascular Access [NA]
The document reports termination of a safety study evaluating a paclitaxel-eluting vascular mesh for hemodialysis vascular access. The study…
-
FDA approval · 2013-02-05FDA Approved: CALCIUM ACETATE — Original Application (Chartwell RX LLC)
FDA approves Chartwell RX LLC's calcium acetate as a new generic phosphate binder under an Original Application (ANDA 202420).
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Study of FG-4592 in Subjects With End-Stage Renal Disease Receiving Maintenance Hemodialysis in China [Phase 2]
Phase 2 study of FG-4592 (roxadustat) for anemia in end-stage renal disease patients on maintenance hemodialysis in China has completed.
-
CLINICAL_TRIALS withdrawal · 2013-02-04Clinical Trial Update: The Impact of Delflex on Mesothelial Cell Viability and Peritoneal Transport [NA]
The clinical trial evaluating Delflex for end-stage renal disease, focusing on mesothelial cell viability and peritoneal transport, has been…
-
FDA approval · 2013-01-30FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care de Mexico, S.A. de C.V.)
FDA approved a supplemental application for DELFLEX, a dialysis solution from Fresenius Medical Care de Mexico, S.A. de C.V.
-
FDA approval · 2013-01-30FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care North America)
FDA approved a supplemental application for DELFLEX, a dialysis solution, from Fresenius Medical Care North America.
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Prevention of Kidney Transplant Rejection [Phase 3]
Phase 3 trial evaluating prevention of kidney transplant rejection has completed; sponsored by NIAID, involving patients with end-stage rena…